MacroGenics | MGNX - Debt

Stock Price
2.98
Daily Change
-0.10 -3.25%
Monthly
72.25%
Yearly
36.70%
Q1 Forecast
2.91

MacroGenics reported $37.01M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Amgen USD 54.59B 1.62B Sep/2025
AstraZeneca USD 32.63B 207M Sep/2025
Biogen USD 6.29B 1.7M Dec/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Daiichi Sankyo JPY 201.14B 99.81B Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Genmab DKK 148M 5M Jun/2025
Geron USD 121.92M 73K Sep/2025
Gilead Sciences USD 24.94B 5M Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Karyopharm Therapeutics USD 264.09M 39.31M Sep/2024
MacroGenics USD 37.01M 238K Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Pfizer USD 60.85B 78M Sep/2025
Puma Biotechnology USD 89.06M 55.07M Jun/2024
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Xencor USD 69.27M 1.34M Sep/2025